TAS2R103 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-10232
Key Product Details
Species Reactivity
Mouse
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of mouse TAS2R103 (NP_444441.1). Peptide sequence WRHLKNMCHSATGSRDVSTVAHIKGLQTVVTFLLLYTAFVMSLLSESLNI
Clonality
Polyclonal
Host
Rabbit
Theoretical MW
35 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Scientific Data Images for TAS2R103 Antibody
Western Blot: TAS2R103 Antibody [NBP3-10232]
Western Blot: TAS2R103 Antibody [NBP3-10232] - Western blot analysis of TAS2R103 in Mouse Heart lysates. Antibody dilution at 1ug/mlApplications for TAS2R103 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: TAS2R103
Alternate Names
EG667992;mGR0;mGR03;mt2r6;mt2r63;T2R3;Tas2r10;Tas2r3;TRB2, T2R23, TAS2R23, TRB
Gene Symbol
Tas2r103
Additional TAS2R103 Products
Product Specific Notices for TAS2R103 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...